CRYO-CELL INTERNATIONAL, INC. Deferred Revenue
CRYO-CELL INTERNATIONAL, INC. (CCEL) had Deferred Revenue of $8.37 million as of 2018-11-30, per its 10-K filed 2019-02-28.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2019-02-28
- 2018-11-30: Deferred Revenue, Current $8.37M.
- 2018-08-31: Deferred Revenue, Current $8.21M.
- 2018-05-31: Deferred Revenue, Current $7.50M.
- 2018-02-28: Deferred Revenue, Current $7.25M.
| Period end | Deferred Revenue, Current |
|---|---|
| 2018-11-30 | $8.37M 10-K · filed 2019-02-28 |
| 2018-08-31 | $8.21M 10-Q · filed 2018-10-15 |
| 2018-05-31 | $7.50M 10-Q · filed 2018-07-16 |
| 2018-02-28 | $7.25M 10-Q · filed 2018-04-16 |
| 2017-11-30 | $7.43M 10-K · filed 2019-02-28 |
| 2017-08-31 | $7.41M 10-Q · filed 2017-10-16 |
| 2017-05-31 | $7.16M 10-Q · filed 2017-07-07 |
| 2017-02-28 | $7.00M 10-Q · filed 2017-04-13 |
| 2016-11-30 | $7.07M 10-K · filed 2018-02-28 |
| 2016-08-31 | $7.09M 10-Q · filed 2016-10-17 |
| 2016-05-31 | $6.87M 10-Q · filed 2016-07-11 |
| 2016-02-29 | $6.61M 10-Q · filed 2016-04-14 |
| 2015-11-30 | $6.78M 10-K · filed 2017-02-28 |
| 2015-08-31 | $6.78M 10-Q · filed 2015-10-15 |
| 2015-05-31 | $6.58M 10-Q · filed 2015-07-15 |
| 2015-02-28 | $6.46M 10-Q · filed 2015-04-14 |
| 2014-11-30 | $6.66M 10-K · filed 2016-02-29 |
| 2014-08-31 | $6.62M 10-Q · filed 2014-10-15 |
| 2014-05-31 | $6.41M 10-Q · filed 2014-07-03 |
| 2014-02-28 | $6.16M 10-Q · filed 2014-04-14 |
| 2013-11-30 | $6.81M 10-K · filed 2015-03-02 |
| 2013-08-31 | $6.75M 10-Q · filed 2013-10-15 |
| 2013-05-31 | $6.56M 10-Q · filed 2013-07-15 |
| 2013-02-28 | $6.37M 10-Q · filed 2013-04-15 |
| 2012-11-30 | $6.54M 10-K · filed 2014-02-28 |
| 2012-08-31 | $6.51M 10-Q · filed 2012-10-15 |
| 2012-05-31 | $6.32M 10-Q · filed 2012-07-16 |
| 2012-02-29 | $6.02M 10-Q · filed 2012-04-16 |
| 2011-11-30 | $6.27M 10-K · filed 2013-02-28 |
| 2011-08-31 | $5.66M 10-Q/A · filed 2011-11-07 |
| 2010-11-30 | $5.47M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |